OpenBilldrug price receipt

NADAC week of 2026-10-14

FLUTICASONE-SALMETEROL 55-14

For 1 unit (EA)

Pharmacies pay

$114.85 filed

1 × $114.84895 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$8.70 filed

1 × $8.70295 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.08× estimated

These two figures may not measure the same thing

At 0.08×, the Medicare figure is 0.2 times what pharmacies pay or less. A gap that large means the two figures may not describe the same unit or product, or the price may have changed between their dates; check what each one covers before relying on the multiple.

This product’s middle NADAC price, $114.84895 per EA, is 70.2× the middle NADAC price of the 5 other products CMS averages under “Fluticasone-Salmeterol” / “Fluticasone Propion/Salmeterol” ($1.63625 per EA), so the Part D average may mostly describe those products, not this one.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$137.08 estimated

$114.85 + $17.23 (15%) + $5.00 fee per fill = $137.08

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FLUTICASONE-SALMETEROL 55-14 is how the CMS NADAC file names this product. The FDA NDC Directory lists it as fluticasone propionate and salmeterol.

FDA gives its dosage form as powder, metered and its route as respiratory (inhalation).

The labeler, the company named on the label, is Teva Pharmaceuticals USA, Inc.

FDA lists it under 2 Established Pharmacologic Classes: beta2-Adrenergic Agonist and Corticosteroid.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00093-3607-82.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $114.85 for 1 unit (EA) (1 × $114.84895 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The NDC

Other strengths, forms and brands

11 other products in the NADAC file share the FDA nonproprietary name fluticasone propionate and salmeterol with FLUTICASONE-SALMETEROL 55-14.

ProductPharmacies pay per unitMedicare per unit
ADVAIR 100-50 DISKUS
brand · powder
$2.48669 per EA filed
eff. 2026-09-23
$3.26156 per EA filed
Part D 2024 average
ADVAIR 250-50 DISKUS
brand · powder
$3.12275 per EA filed
eff. 2026-09-23
$3.26156 per EA filed
Part D 2024 average
ADVAIR 500-50 DISKUS
brand · powder
$4.2281 per EA filed
eff. 2026-09-23
$3.26156 per EA filed
Part D 2024 average
FLUTICASONE-SALMETEROL 55-14 this page
generic · powder, metered
$114.84895 per EA filed
eff. 2026-09-23
$8.70295 per EA filed
Part D 2024 average
FLUTICASONE-SALMETEROL 100-50
generic · powder
$1.07358 per EA filed
eff. 2026-09-23 to 2026-10-07
$8.70295 per EA filed
Part D 2024 average
FLUTICASONE-SALMETEROL 113-14
generic · powder, metered
$108.27886 per EA filed
eff. 2026-09-23
$8.70295 per EA filed
Part D 2024 average
FLUTICASONE-SALMETEROL 232-14
generic · powder, metered
$105.32145 per EA filed
eff. 2026-09-23
$8.70295 per EA filed
Part D 2024 average
FLUTICASONE-SALMETEROL 250-50
generic · powder
$1.24514 per EA filed
eff. 2026-09-23 to 2026-10-07
$8.70295 per EA filed
Part D 2024 average
FLUTICASONE-SALMETEROL 500-50
generic · powder
$1.63625 per EA filed
eff. 2026-09-23
$8.70295 per EA filed
Part D 2024 average
WIXELA 100-50 INHUB
generic · powder
$1.07358 per EA filed
eff. 2026-09-23
$1.58021 per EA filed
Part D 2024 average
WIXELA 250-50 INHUB
generic · powder
$1.24514 per EA filed
eff. 2026-09-23
$1.58021 per EA filed
Part D 2024 average
WIXELA 500-50 INHUB
generic · powder
$1.63625 per EA filed
eff. 2026-09-23
$1.58021 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $114.84895 per EA filed.

Of the 26 other products in FDA’s beta2-Adrenergic Agonist class priced per EA, 0 have a higher middle NADAC price and 26 a lower one. The one in the middle is FLUTICASONE-VILANTEROL 200-25, at $3.91371 per EA filed (eff. 2026-09-23).

Of the 73 other products in FDA’s Corticosteroid class priced per EA, 3 have a higher middle NADAC price and 70 a lower one. The one in the middle is FLUTICASONE PROP 100 MCG DISKUS, at $2.05252 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $8.70 for 1 unit (EA), at an average of $8.70295 per EA in 2024 (2024-01-01 to 2024-12-31) for “Fluticasone-Salmeterol” and “Fluticasone Propion/Salmeterol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 2,594,479 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for FLUTICASONE-SALMETEROL 55-14 labelled estimated?
Beyond what the card shows, the records give these reasons: Part D averages every strength and form sold under “Fluticasone-Salmeterol” / “Fluticasone Propion/Salmeterol” into one figure, so it is not specific to this NDC. The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Fluticasone-Salmeterol / Fluticasone Propion/Salmeterol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists its NDC as dosage form “POWDER, METERED” with route “RESPIRATORY (INHALATION)”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.